{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:47:06Z","timestamp":1779886026002,"version":"3.53.1"},"reference-count":140,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"vor","delay-in-days":8628,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1996]]},"DOI":"10.1254\/jjp.71.187","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T05:16:18Z","timestamp":1201151778000},"page":"187-204","source":"Crossref","is-referenced-by-count":29,"title":["Dopamine and Serotonin Receptors: Amino Acid Sequences, and Clinical Role in Neuroleptic Parkinsonism"],"prefix":"10.1016","volume":"71","author":[{"given":"Philip","family":"Seeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert H.M.","family":"Van Tol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.71.187_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0922-4106(92)90129-J","article-title":"Site-directed mutagenesis of the human dopamine D2 receptor","volume":"227","author":"Mansour","year":"1992","journal-title":"Eur J Pharmacol (Mol Pharmacol Sect)"},{"key":"10.1254\/jjp.71.187_bib2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1471-4159.1992.tb09416.x","article-title":"Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors","volume":"59","author":"Cox","year":"1992","journal-title":"J Neurochem"},{"key":"10.1254\/jjp.71.187_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ajmg.1320540419","article-title":"Dopamine D4 receptor variant, D4GLYCINE194, in Africans, but not in Caucasians. No association with schizophrenia","volume":"54","author":"Seeman","year":"1994","journal-title":"Am J Med Gen (Neuropsychiatric Genet)"},{"key":"10.1254\/jjp.71.187_bib4","first-page":"8","article-title":"Three-dimensional models of neurotransmitter G-binding protein-coupled receptors","volume":"40","author":"Hibert","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.71.187_bib5","first-page":"733","article-title":"Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase","volume":"39","author":"Neve","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.71.187_bib6","doi-asserted-by":"crossref","first-page":"29557","DOI":"10.1016\/S0021-9258(18)43916-6","article-title":"Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of alpha2-adrenergic receptor-G-protein interactions","volume":"269","author":"Ceresa","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1254\/jjp.71.187_bib7","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/0006-2952(92)90092-W","article-title":"Conversion of the human 5-HT1Dbeta serotonin receptor to the rat 5-HT1B ligand-binding phenotype by Thr355Asn site directed mutagenesis","volume":"44","author":"Metcalf","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1254\/jjp.71.187_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/360161a0","article-title":"A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors","volume":"360","author":"Oksenberg","year":"1992","journal-title":"Nature"},{"key":"10.1254\/jjp.71.187_bib9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1471-4159.1993.tb05865.x","article-title":"A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine1B receptors","volume":"60","author":"Parker","year":"1993","journal-title":"J Neurochem"},{"key":"10.1254\/jjp.71.187_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0028-3908(94)90068-X","article-title":"A single point mutation increases the affinity of serotonin 5-HT1D alpha, 5-HT1D beta, 5-HT1E, and 5-HT1F receptors for beta-adrenergic antagonists","volume":"33","author":"Adham","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1254\/jjp.71.187_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0922-4106(91)90001-X","article-title":"Molecular biology of the dopamine receptors","volume":"207","author":"Civelli","year":"1991","journal-title":"Eur J Pharmacol (Mol Pharmacol Sect)"},{"key":"10.1254\/jjp.71.187_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/syn.890180310","article-title":"Molecular biology of serotonin (5-HT) receptors","volume":"18","author":"Peroutka","year":"1994","journal-title":"Synapse"},{"key":"10.1254\/jjp.71.187_bib13","first-page":"157","article-title":"VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)","volume":"46","author":"Hoyer","year":"1994","journal-title":"Pharmacol Rev"},{"key":"10.1254\/jjp.71.187_bib14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0165-6147(00)89034-3","article-title":"New players in the 5-HT receptor field: genes and knockouts","volume":"16","author":"Lucas","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1254\/jjp.71.187_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/(SICI)1096-8628(19960122)61:3<277::AID-AJMG14>3.0.CO;2-Q","article-title":"The dopamine D4 receptor variant in Africans, D4Valine194Giycine, is insensitive to dopamine and clozapine. Report of a homozygous individual","volume":"61","author":"Liu","year":"1996","journal-title":"Am J Med Gen"},{"key":"10.1254\/jjp.71.187_bib16","first-page":"246","article-title":"Dopamine receptor-block and nigral fiber-impulse blockade by major tranquilizers","volume":"33","author":"Seeman","year":"1974","journal-title":"Fed Proc"},{"key":"10.1254\/jjp.71.187_bib17","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1073\/pnas.72.11.4376","article-title":"Brain receptors for antipsychotic drugs and dopamine: Direct binding assays","volume":"72","author":"Seeman","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.71.187_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1254\/jjp.71.187_bib19","first-page":"261","article-title":"Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2, clozapine occupies D4","volume":"7","author":"Seeman","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1254\/jjp.71.187_bib20","first-page":"28","article-title":"Dopamine receptors and psychosis","volume":"2","author":"Seeman","year":"1995","journal-title":"[Scientific American] Science and Medicine"},{"key":"10.1254\/jjp.71.187_bib21","first-page":"587","article-title":"Effects of antipsychotic drugs on serotonin receptors","volume":"43","author":"Meltzer","year":"1991","journal-title":"Pharmacol Rev"},{"key":"10.1254\/jjp.71.187_bib22","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/BF00442554","article-title":"Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia","volume":"99","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology (Berlin)"},{"issue":"Supp 1","key":"10.1254\/jjp.71.187_bib23","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1097\/00004714-199502001-00001","article-title":"The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics","volume":"15","author":"Meitzer","year":"1995","journal-title":"J Clin Psychopharmacol"},{"issue":"Supp 3","key":"10.1254\/jjp.71.187_bib24","first-page":"467S","article-title":"Finely balanced 5HT2\/D2-antagonism: A crucial factor for the treatment of schizophrenia","volume":"10","author":"Leysen","year":"1994","journal-title":"Neuropsychopharmacology"},{"issue":"Supp 1","key":"10.1254\/jjp.71.187_bib25","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1097\/00004714-199502001-00002","article-title":"The evolution of the serotonin-dopamine antagonist concept","volume":"15","author":"Huttunen","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"10.1254\/jjp.71.187_bib26","first-page":"749","article-title":"Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B and D3 receptors","volume":"43","author":"Malmberg","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.71.187_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0922-4106(95)90125-6","article-title":"Deriving the therapeutic concentrations for clozapine and haloperidol: The apparente\u00e1\u00e9issociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand","volume":"291","author":"Seeman","year":"1995","journal-title":"Eur J Pharmacol (Mol Pharmacol Section)"},{"issue":"Supp 3","key":"10.1254\/jjp.71.187_bib28","first-page":"5","article-title":"Therapeutic receptor-blocking concentrations of neuroleptics","volume":"10","author":"Seeman","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1254\/jjp.71.187_bib29","first-page":"252.1","article-title":"The apparent relative selectivity of dopamine antagonists for dopamine D2 and D4 receptor clones depends on the radioligand used","volume":"21","author":"Durcan","year":"1995","journal-title":"Soc Neurosci Abstr"},{"key":"10.1254\/jjp.71.187_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF01271545","article-title":"Characterization of [3H]clozapine binding sites in rat brain","volume":"101","author":"Kusumi","year":"1995","journal-title":"J Neural Transm"},{"key":"10.1254\/jjp.71.187_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01271560","article-title":"Long-term treatment with haloperidol or clozapine does not affect dopamine D4 receptors in rat frontal cortex","volume":"101","author":"Kusumi","year":"1995","journal-title":"J Neural Transm"},{"key":"10.1254\/jjp.71.187_bib32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF03401577","article-title":"Clozapine: Selective labeling of sites resembling 5HT6 serotonin receptors may reflect psychoactive profile","volume":"1","author":"Glatt","year":"1995","journal-title":"Mol Med"},{"key":"10.1254\/jjp.71.187_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0306-4522(92)90470-M","article-title":"Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum","volume":"51","author":"Kawagoe","year":"1992","journal-title":"Neuroscience"},{"key":"10.1254\/jjp.71.187_bib34","first-page":"364","article-title":"Dopamine D4 receptor repeat: Analysis of different native and mutant forms of the human rat genes","volume":"46","author":"Asghari","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.71.187_bib35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine","volume":"49","author":"Farde","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1254\/jjp.71.187_bib36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF02246112","article-title":"Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study","volume":"117","author":"Olesen","year":"1995","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1254\/jjp.71.187_bib37","first-page":"39","article-title":"Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson\u2019s disease","volume":"12","author":"Meitzer","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1254\/jjp.71.187_bib38","first-page":"1","article-title":"D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients","volume":"55","author":"Farde","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"Supp 3, Part 1","key":"10.1254\/jjp.71.187_bib39","first-page":"695S","article-title":"The mechanism of antipsychotic drug action examined by PET in schizophrenic patients","volume":"10","author":"Nordstr\u00f6m","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1254\/jjp.71.187_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01250702","article-title":"Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol","volume":"86","author":"Karbe","year":"1991","journal-title":"J Neural Transm"},{"key":"10.1254\/jjp.71.187_bib41","series-title":"New Generation of Antipsychotic Drugs: Novel Mechanisms of Action","first-page":"130","article-title":"Dopamine (D2)-receptor occupancy in clozapine-treated patients as measured by positron emission tomography using 18FESP","volume":"Vol. 4","author":"Louwerens","year":"1993"},{"key":"10.1254\/jjp.71.187_bib42","first-page":"1403","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors","volume":"268","author":"Roth","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.71.187_bib43","series-title":"Psychopharmacology: The Fourth Generation of Progress","first-page":"295","article-title":"Dopamine receptors. Clinical correlates","author":"Seeman","year":"1995"},{"key":"10.1254\/jjp.71.187_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/syn.890030113","article-title":"Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]-raclopride: implications for positron emission tomography of the human brain","volume":"3","author":"Seeman","year":"1989","journal-title":"Synapse"},{"key":"10.1254\/jjp.71.187_bib45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/syn.890090305","article-title":"Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain","volume":"9","author":"Young","year":"1991","journal-title":"Synapse"},{"key":"10.1254\/jjp.71.187_bib46","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1523\/JNEUROSCI.12-10-03773.1992","article-title":"GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography","volume":"12","author":"Dewey","year":"1992","journal-title":"J Neurosci"},{"key":"10.1254\/jjp.71.187_bib47","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/syn.890130407","article-title":"Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels","volume":"13","author":"Dewey","year":"1993","journal-title":"Synapse"},{"key":"10.1254\/jjp.71.187_bib48","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1073\/pnas.90.24.11816","article-title":"Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects","volume":"90","author":"Dewey","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.71.187_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/syn.890100302","article-title":"Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates","volume":"10","author":"Innis","year":"1992","journal-title":"Synapse"},{"key":"10.1254\/jjp.71.187_bib50","first-page":"227","article-title":"Quantification of human intrasynaptic dopamine release by iv cocaine and amphetamine","volume":"34","author":"Wong","year":"1995","journal-title":"Am Coll Neuropsychopharmacol"},{"key":"10.1254\/jjp.71.187_bib51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0024-3205(86)90652-1","article-title":"Exogenous 1-DOPA alters spiroperidol binding, in vivo, in the mouse striatum","volume":"39","author":"De Jesus","year":"1986","journal-title":"Life Sci"},{"key":"10.1254\/jjp.71.187_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/syn.890090306","article-title":"Elfects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons","volume":"9","author":"Logan","year":"1991","journal-title":"Synapse"},{"key":"10.1254\/jjp.71.187_bib53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/syn.890070409","article-title":"Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography","volume":"7","author":"Dewey","year":"1991","journal-title":"Synapse"},{"key":"10.1254\/jjp.71.187_bib54","first-page":"1182","article-title":"SPECT imaging of striatal dopamine release after amphetamine challenge","volume":"36","author":"Laruelle","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1254\/jjp.71.187_bib55","first-page":"159","article-title":"SPECT imaging of synaptic dopamine release in drug-free schizophrenic patients","volume":"34","author":"Laruelle","year":"1995","journal-title":"Am Coll Neuropsychopharmacol (Abstr)"},{"key":"10.1254\/jjp.71.187_bib56","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.2042-7158.1973.tb10025.x","article-title":"Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system","volume":"25","author":"And\u00e9n","year":"1973","journal-title":"J Pharm Pharmacol"},{"key":"10.1254\/jjp.71.187_bib57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-2999(84)90438-2","article-title":"Homovanillic acid in caudate and pre-frontal cortex following neuroleptics","volume":"99","author":"Bowers","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.71.187_bib58","first-page":"276","article-title":"Time course for dopamine and serotonin receptor occupancy in the brain of schizophrenic patients following dosing with 150 mg Seroquel\u2122 (ICI 204,636) TID","volume":"34","author":"Gefvert","year":"1995","journal-title":"Am Coll Neuropsychopharmacol"},{"key":"10.1254\/jjp.71.187_bib59","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0920-9964(96)85619-2","article-title":"SPECT imaging of synaptic dopamine release in drug free schizophrenic patients: An experimental validation of the dopamine hypothesis of schizophrenia","volume":"18","author":"Laruelle","year":"1996","journal-title":"Schizophrenia Res"},{"issue":"Supp 358","key":"10.1254\/jjp.71.187_bib60","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0447.1990.tb05280.x","article-title":"Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage","volume":"82","author":"Seeman","year":"1990","journal-title":"Acta Psychiatry Scand"},{"key":"10.1254\/jjp.71.187_bib61","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/jm00130a006","article-title":"Sterically hindered 5,1-dicarbo analogues of clozapine as potential chiral antipsychotic agents","volume":"32","author":"Rupard","year":"1989","journal-title":"J Med Chem"},{"key":"10.1254\/jjp.71.187_bib62","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1254\/jjp.71.187_bib63","first-page":"85P","article-title":"The serotonin-dopamine interaction measured with positron emission tomography (PET) and C-ll raclopride in normal human subjects","volume":"35","author":"Smith","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1254\/jjp.71.187_bib64","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1523\/JNEUROSCI.15-01-00821.1995","article-title":"Serotonergic modulation of striatal dopamine measured with positron emission tomograpghy (PET) and in vivo microdialysis","volume":"15","author":"Dewey","year":"1995","journal-title":"J Neurosci"},{"key":"10.1254\/jjp.71.187_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0920-9964(95)95500-9","article-title":"Systemic and intracortical administration of ritanserin increases in vivo dopamine release in rat prefrontal cortex","volume":"15","author":"Pehek","year":"1995","journal-title":"Schizophrenia Res"},{"key":"10.1254\/jjp.71.187_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0920-9964(95)95477-Q","article-title":"5HT2-Receptor antagonists can attenuate submaximal haloperidol-induced catalepsy in rats","volume":"15","author":"Bligh-Glover","year":"1995","journal-title":"Schizophrenia Res"},{"key":"10.1254\/jjp.71.187_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01245351","article-title":"Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat","volume":"89","author":"Wadenberg","year":"1992","journal-title":"J Neural Transm"},{"key":"10.1254\/jjp.71.187_bib68","first-page":"225","article-title":"Clozapine\u2019s inability to induce experimental catalepsy is not altered by changes in serotonergic transmission","volume":"20","author":"Jaskiw","year":"1994","journal-title":"Soc Neurosci Abstr"},{"key":"10.1254\/jjp.71.187_bib69","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00002826-199012000-00003","article-title":"5-HT2 antagonist ritanserin in neuroleptic-induced ParkinsonismA double-blind comparison with orphenadrine and placebo","volume":"13","author":"Bersani","year":"1990","journal-title":"Clin Neuropharmacol"},{"key":"10.1254\/jjp.71.187_bib70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0278-5846(92)90076-Q","article-title":"The effect of ritanserin on treatment-resistant neuroleptic induced akathisia: Case reports","volume":"16","author":"Miller","year":"1992","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1254\/jjp.71.187_bib71","first-page":"127","article-title":"The effect of a serotonin S2 antagonist, ritanserine, and an anticholinergic benztropine on haloperidol-induced dystonia in nonhuman primates","volume":"30","author":"Casey","year":"1991","journal-title":"Am Coll Neuropsychopharmacol (Abstr)"},{"key":"10.1254\/jjp.71.187_bib72","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/BF02245007","article-title":"Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primates","volume":"112","author":"Casey","year":"1993","journal-title":"Psychopharmacology (Berlin)"},{"issue":"Supp 3","key":"10.1254\/jjp.71.187_bib73","first-page":"105","article-title":"Motor and mental aspects of extrapyramidal syndromes","volume":"10","author":"Casey","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1254\/jjp.71.187_bib74","series-title":"Schizophrenia, Alfred Benzon Symposium 38","first-page":"287","article-title":"The nonhuman primate model: Focus on dopamine D2 and sertonin mechanisms","author":"Casey","year":"1995"},{"key":"10.1254\/jjp.71.187_bib75","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0028-3908(88)90134-7","article-title":"8-Hydroxy-2-(di-N-propylamino)tetralin, a selective serotonin 1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis","volume":"27","author":"Invernizzi","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1254\/jjp.71.187_bib76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00174869","article-title":"Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine","volume":"338","author":"Broekkamp","year":"1988","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1254\/jjp.71.187_bib77","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/0024-3205(90)90365-X","article-title":"The effect of serotonergic agents on haloperidol-induced catalepsy","volume":"47","author":"Hicks","year":"1990","journal-title":"Life Sci"},{"key":"10.1254\/jjp.71.187_bib78","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01244451","article-title":"Antipsychotic-like profile of combined treatment with raclopride and 8-OHDPAT in the rat: enhancement of antipsychotic-like effects without catalepsy","volume":"83","author":"Wadenberg","year":"1991","journal-title":"J Neural Transm"},{"key":"10.1254\/jjp.71.187_bib79","first-page":"109","article-title":"The effect of 8-OH-DPAT on haloperidol-induced dystonia in nonhuman primates","volume":"32","author":"Casey","year":"1992","journal-title":"Am Coll Neuropsychopharmacol (Abstr)"},{"key":"10.1254\/jjp.71.187_bib80","first-page":"207","article-title":"Serotonergic involvement in haloperidol-induced catalepsy","volume":"265","author":"Neal-Beliveau","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.71.187_bib81","first-page":"301","article-title":"[3H]Ketanserin (R41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role","volume":"21","author":"Leysen","year":"1982","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.71.187_bib82","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-2999(87)90544-9","article-title":"Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro","volume":"143","author":"Wander","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.71.187_bib83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02246146","article-title":"Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors","volume":"120","author":"Corbett","year":"1995","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1254\/jjp.71.187_bib84","first-page":"238","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamin D-1, D-2 and serotonin2 pKj values","volume":"251","author":"Meitzer","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.71.187_bib85","first-page":"390","article-title":"The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs","volume":"25","author":"Meitzer","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"10.1254\/jjp.71.187_bib86","first-page":"498","article-title":"Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo","volume":"265","author":"Matsubara","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.71.187_bib87","first-page":"1374","article-title":"Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors","volume":"266","author":"Stockmeier","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1254\/jjp.71.187_bib88","first-page":"361","article-title":"Gaps and peculiarities in 5-HT2 receptor studies","volume":"3","author":"Leysen","year":"1990","journal-title":"Neuropsychopharmacology"},{"key":"10.1254\/jjp.71.187_bib89","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0922-4106(93)90126-T","article-title":"Clozapine and N- desmethylclozapine are potent 5-HT1c receptor antagonists","volume":"245","author":"Kuoppam\u00e4ki","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.71.187_bib90","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1471-4159.1996.66010047.x","article-title":"Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor","volume":"66","author":"Kohen","year":"1996","journal-title":"J Neurochem"},{"key":"10.1254\/jjp.71.187_bib91","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(94)90012-4","article-title":"Clozapine inhibits serotoninergic transmission by an action at aradrenoceptors not at 5-HT1A receptors","volume":"260","author":"Lejeune","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.71.187_bib92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(89)90438-X","article-title":"Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact?","volume":"171","author":"Hoyer","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.71.187_bib93","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02311185","article-title":"D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs","volume":"120","author":"Roth","year":"1995","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1254\/jjp.71.187_bib94","first-page":"278","article-title":"Efficacy, safety, and dose response of three doses of sertindole and three doses of Haldol in schizophrenic patients","volume":"34","author":"Daniel","year":"1995","journal-title":"Am Coll Neuropsychopharmacol (Abstr)"},{"key":"10.1254\/jjp.71.187_bib95","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/347080a0","article-title":"Human dopamine Dj receptor encoded by an intronless gene on chromosome 5","volume":"347","author":"Sunahara","year":"1990","journal-title":"Nature"},{"key":"10.1254\/jjp.71.187_bib96","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1073\/pnas.86.24.9762","article-title":"Cloning of the cDNA and gene for a human D2 dopamine receptor","volume":"86","author":"Grandy","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.71.187_bib97","first-page":"501","article-title":"Clonage du g\u00e8ne du r\u00e9cepteur dopaminergique D3 humain et identification de son chromosome","volume":"311","author":"Giros","year":"1990","journal-title":"Comptes Rendu Acad Sci Paris"},{"key":"10.1254\/jjp.71.187_bib98","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/350610a0","article-title":"Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine","volume":"350","author":"Van Toi","year":"1991","journal-title":"Nature"},{"key":"10.1254\/jjp.71.187_bib99","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/358149a0","article-title":"Multiple dopamine D4 receptor variants in the human population","volume":"358","author":"Van Toi","year":"1992","journal-title":"Nature"},{"key":"10.1254\/jjp.71.187_bib100","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/350614a0","article-title":"Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than Dj","volume":"350","author":"Sunahara","year":"1991","journal-title":"Nature"},{"key":"10.1254\/jjp.71.187_bib101","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0893-133X(94)00085-E","article-title":"The gene encoding the 5-HT1A receptor is intact in mood disorders","volume":"12","author":"Xie","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1254\/jjp.71.187_bib102","first-page":"516","article-title":"Identification of residues important for ligand binding to the human 5-hydroxytrytamineiA serotonin receptor","volume":"43","author":"Chanda","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.71.187_bib103","first-page":"143","article-title":"Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor","volume":"40","author":"Hamblin","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.71.187_bib104","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1016\/S0021-9258(18)42552-5","article-title":"Molecular cloning of a human serotonin receptor (SI2) with a pharmacological profile resembling that of the 5-HT1D subtype","volume":"267","author":"Levy","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1254\/jjp.71.187_bib105","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1073\/pnas.89.12.5522","article-title":"A human serotonin ID receptor variant (5HT1D\/3) encoded by an intronless gene on chromosome 6","volume":"89","author":"Demchyshyn","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.71.187_bib106","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1016\/S0021-9258(18)42612-9","article-title":"Characterization of the human 5-hydroxytryptamineiB receptor","volume":"267","author":"Jin","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1254\/jjp.71.187_bib107","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1073\/pnas.89.8.3630","article-title":"Human serotonin ID receptor is encoded by a subfamily of two distinct genes: 5-HT1Dalpha and 5-HT1Dbeta","volume":"89","author":"Weinshank","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.71.187_bib108","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-5793(92)80379-U","article-title":"Molecular cloning of a human gene (S31) encoding a novel serotonin receptor mediating inhibition of adenylyl cyclcase","volume":"296","author":"Levy","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1254\/jjp.71.187_bib109","first-page":"180","article-title":"Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamineiE receptor","volume":"42","author":"Zgombick","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.71.187_bib110","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1073\/pnas.89.12.5517","article-title":"Molecular cloning of a serotonin receptor from human brain (5HT1E): A fifth 5HTl-like subtype","volume":"89","author":"McAllister","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.71.187_bib111","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0169-328X(92)90005-V","article-title":"The human 5-HT2 receptor is encoded by a multiple intron-exon gene","volume":"14","author":"Chen","year":"1992","journal-title":"Mol Br Res"},{"key":"10.1254\/jjp.71.187_bib112","first-page":"227","article-title":"Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor","volume":"46","author":"Kursar","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.71.187_bib113","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-291X(91)92105-S","article-title":"Cloning of the human serotonin 5-HT1C receptor subtypes","volume":"181","author":"Saltzmann","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1254\/jjp.71.187_bib114","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/j.1460-2075.1995.tb07280.x","article-title":"The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants","volume":"14","author":"Gerald","year":"1995","journal-title":"EMBO J"},{"key":"10.1254\/jjp.71.187_bib115","first-page":"1266","article-title":"The 5-HT4 receptor: molecular cloning and pharmacological characterization of the human 5-HT4L receptor","volume":"20","author":"Gerald","year":"1994","journal-title":"Soc Neurosci Abstr"},{"key":"10.1254\/jjp.71.187_bib116","doi-asserted-by":"crossref","unstructured":"Rees S, den Daas I, Foord S, Goodson S, Bull D, Kilpatrick G and Lee M: Cloning and characterization of the human 5-HT5A serotonin receptor. FEBS Lett 355, 242\u2013246","DOI":"10.1016\/0014-5793(94)01209-1"},{"key":"10.1254\/jjp.71.187_bib117","doi-asserted-by":"crossref","first-page":"23422","DOI":"10.1016\/S0021-9258(19)49479-9","article-title":"Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase","volume":"268","author":"Bard","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1254\/jjp.71.187_bib118","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/336783a0","article-title":"Cloning and expression of rat D2 dopamine receptor cDNA","volume":"336","author":"Bunzow","year":"1988","journal-title":"Nature"},{"key":"10.1254\/jjp.71.187_bib119","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Kx) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"issue":"Supp 1","key":"10.1254\/jjp.71.187_bib120","first-page":"383","article-title":"Construction and characterization of stable mammalian cell lines expressing human D4 dopamine receptors","volume":"72","author":"Owolabi","year":"1994","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1254\/jjp.71.187_bib121","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0014-5793(90)80140-E","article-title":"Cloning of two additional catecholamine receptors from rat brain","volume":"262","author":"O\u2019Dowd","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1254\/jjp.71.187_bib122","doi-asserted-by":"crossref","unstructured":"Markstein R, Gull P, R\u00fcdeberg C, Urwyler S, Jaton AL, Kalkman HO, Dixon AK and Hoyer D: SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors. J Neural Transm (1995) (in press)","DOI":"10.1007\/BF01292613"},{"key":"10.1254\/jjp.71.187_bib123","first-page":"841","article-title":"\u00dcber eine neue chemische Gruppe stark wirksamer Neuroleptica. 5. Mittelung \u00fcber siebengliederige Heterocylclen","volume":"15","author":"Stille","year":"1965","journal-title":"Arzneimittelforschung"},{"key":"10.1254\/jjp.71.187_bib124","first-page":"117","article-title":"Absicht und Zufall in der Arznmittelforschung, dargelegt am beispiel der trizyklischen Psychopharmaka","volume":"48","author":"Schmutz","year":"1973","journal-title":"Pharmaceut Acta Helv"},{"key":"10.1254\/jjp.71.187_bib125","series-title":"Chronicles of Drug Discovery","first-page":"39","article-title":"Clozapine","volume":"Vol 1","author":"Schmutz","year":"1992"},{"key":"10.1254\/jjp.71.187_bib126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-1119(91)90611-E","article-title":"Human dopamine D5 receptor human pseudogenes","volume":"109","author":"Nguyen","year":"1991","journal-title":"Gene"},{"key":"10.1254\/jjp.71.187_bib127","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jama.1994.03510270050038","article-title":"No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis","volume":"271","author":"Gejman","year":"1994","journal-title":"J Am Med Assoc"},{"key":"10.1254\/jjp.71.187_bib128","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1006\/bbrc.1993.2404","article-title":"A structural polymorphism of human dopamine D2 receptor","volume":"196","author":"Itokawa","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1254\/jjp.71.187_bib129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00041444-199210000-00003","article-title":"Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders","volume":"2","author":"Lannfelt","year":"1992","journal-title":"Psychiatric Gen"},{"key":"10.1254\/jjp.71.187_bib130","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1073\/pnas.90.19.8942","article-title":"Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia","volume":"90","author":"Schmauss","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.71.187_bib131","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/bbrc.1993.1829","article-title":"Expression of the D3 dopamine receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes","volume":"194","author":"Nagai","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1254\/jjp.71.187_bib132","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0006-291X(05)81169-6","article-title":"Alternative transcripts of the rat and human dopamine D3 receptor","volume":"180","author":"Snyder","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1254\/jjp.71.187_bib133","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/hmg\/2.6.767","article-title":"A hypervariable segment in the human dopamine receptor D4 (DRD4) gene","volume":"2","author":"Lichter","year":"1993","journal-title":"Hum Mol Gen"},{"key":"10.1254\/jjp.71.187_bib134","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0006-3223(93)90236-7","article-title":"Distribution of a novel mutation in the first exon of the human dopamine D4 receptor gene in psychotic patients","volume":"34","author":"Catalano","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1254\/jjp.71.187_bib135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajmg.1320600509","article-title":"Systematic screening for mutations in the promoter and the coding region of the 5-HT1A gene","volume":"60","author":"Erdmann","year":"1995","journal-title":"Am J Med Gen (Neuropsychiatry Gen)"},{"key":"10.1254\/jjp.71.187_bib136","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/bbrc.1996.0322","article-title":"A serotonin receptor gene (5HT1A) variant found in a Tourette\u2019s syndrome patient","volume":"219","author":"Lam","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1254\/jjp.71.187_bib137","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1006\/bbrc.1994.2792","article-title":"Identification of genetic variation in the human serotonin lDbeta receptor gene","volume":"205","author":"N\u00f6then","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1254\/jjp.71.187_bib138","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1073\/pnas.90.2.408","article-title":"Cloning of another human serotonin receptor (5-HT1F): A fifth 5-HTi receptor subtype coupled to the inhibition of adenylate cyclase","volume":"90","author":"Adham","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.71.187_bib139","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/geno.1995.1042","article-title":"Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2C receptor gene (HTR2C)","volume":"27","author":"Lappalainen","year":"1995","journal-title":"Genomics"},{"key":"10.1254\/jjp.71.187_bib140","first-page":"313","article-title":"Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors: define a new family of serotonin receptors: Cloning, functional expression, and chromosomal localization","volume":"43","author":"Matthes","year":"1993","journal-title":"Mol Pharmacol"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819352680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819352680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T14:28:40Z","timestamp":1630592920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819352680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"references-count":140,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996]]}},"alternative-id":["S0021519819352680"],"URL":"https:\/\/doi.org\/10.1254\/jjp.71.187","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1996]]}}}